Quoin Pharmaceuticals Ltd ADR (QNRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,125 | 3,818 | 1,831 | 1,669 | 3,822 |
| Marketable Securities | 10,919 | 14,927 | 3,582 | 6,122 | 7,731 |
| TOTAL | $15,335 | $20,007 | $6,015 | $8,479 | $12,497 |
| Non-Current Assets | |||||
| Intangibles | 358 | 383 | 408 | 433 | 458 |
| TOTAL | $358 | $383 | $408 | $433 | $458 |
| Total Assets | $15,693 | $20,391 | $6,424 | $8,913 | $12,955 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,376 | 1,862 | 2,461 | 1,474 | 1,244 |
| Accrued Expenses | 2,970 | 3,685 | 3,304 | 2,864 | 3,612 |
| TOTAL | $5,346 | $5,547 | $5,765 | $4,338 | $4,856 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,574 | 1,724 | 1,874 | 2,024 | 2,174 |
| TOTAL | $1,574 | $1,724 | $1,874 | $2,024 | $2,174 |
| Total Liabilities | $6,920 | $7,271 | $7,638 | $6,361 | $7,029 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 1,804 | 839 | 588 | 588 |
| Retained earnings | -75,968 | -70,970 | -66,622 | -62,674 | -58,978 |
| Other shareholders' equity | 0 | -1 | 0 | 0 | 0 |
| TOTAL | $8,773 | $13,120 | $-1,215 | $2,551 | $5,926 |
| Total Liabilities And Equity | $15,693 | $20,391 | $6,424 | $8,913 | $12,955 |